Dalhousie HPB/Transplant Surgery
@DalHPB
Providing hepatobiliary, pancreas, and transplant surgical care, research, & education in Atlantic Canada.
That’s a wrap to 2023! We took a page from @Spotify and did a wrapped for our transplants.
In 2023, our small but mighty program performed: - 116 kidney transplants 28 living donors - 23 liver transplants Looking forward to a new year of transplants in Atlantic Canada!! @ASTSChimera @LegacyofLifeNS @cst_transplant @CNTRP @boris_gala @nickpat9 @ZuhaibMir
Gonna miss this beauty. We had some fun too in between all his incredibly hard work. Welcome Dr. Kohei Kinoshita to the team.
Proud of our fellows, Dr. Santiago Rubio (Kidney Transplant) and Dr. Zuhaib Mir (HPB/Liver Transplant) on successfully completing their training with us. With 300+ transplants, you have helped change so many lives in Atlantic Canada! @ASTSChimera @AHPBA @CHPBAsurg
Proud of our fellows, Dr. Santiago Rubio (Kidney Transplant) and Dr. Zuhaib Mir (HPB/Liver Transplant) on successfully completing their training with us. With 300+ transplants, you have helped change so many lives in Atlantic Canada! @ASTSChimera @AHPBA @CHPBAsurg




Last month, our Kidney Transplant fellow Dr. Santiago Rubio completed 200 kidney transplants so far in fellowship! Watch out for this rising ⭐️ in transplant surgery!


Thanks for hosting! We are very excited to start our robotic HPB/transplant program to advance patient care and surgical education in Atlantic Canada! @DalhousieU @DALsurgresearch @QEIIFoundation @CHPBAsurg @cst_transplant @CAGS_ACCG @boris_gala
We had the honor to host our colleagues from Dalhousie University in Halifax Canada for observing Robotic Right Posterior liver resection for 10cm tumor. Drs. Boriz Lopez and Steph Hiebert are both Transplant and HPB surgeons. We learned from each other techniques and practices.
We are hiring an academic HPB/Transplant surgeon! University-based clinical practice with full spectrum of benign/malignant HPB + renal transplant + liver transplant. nshdocs.morethanmedicine.ca/opportunities/… @AHPBA @ASTSChimera @CHPBAsurg @CAGS_ACCG @DALsurgresearch @cst_transplant
5⃣P Pouramin @DalHPB: median MELD at transplant minus 3 (MMaT-3) exception points system can ⬇️ waitlist for non-HCC transplant patients, levelling the playing field without negatively impacting HCC patients outcomes #CSF2024
From phenomenal research, to technical tips, to ergonomics, to learning more about truth & reconciliation, to catching up with colleagues & friends, to Nuit Blanche, @CAGS_ACCG #CSF2024 and @cityofwinnipeg delivered on all fronts!
Great representation by our trainees and faculty at #CSF2024 @CAGS_ACCG @DALsurgresearch @ZuhaibMir @CHPBAsurg @boris_gala




1⃣ @ZuhaibMir @DalHPB: emerging strategies like prostaglandin administration and machine perfusion may reduce ischemia-reperfusion injury in liver transplants for HCC, boosting recurrence-free survival. More work to come! #CSF2024
Strong work @mdfaleiro! Strategies to ⬇️ ischemia-reperfusion injury during liver transplant for patients with HCC were associated with: ⬇️ inflammation ⬇️ recurrence ↔️ no change in overall survival @DalHPB @DALsurgresearch @boris_gala @cst_transplant @CHPBAsurg @ASTSChimera
Our systematic review on novel strategies to reduce allograft ischemia-reperfusion injury in liver transplantation for HCC has been published at @CurrentOncology! As a future transplant surgeon, I couldn't be happier to be part of this team! Link: bit.ly/3V7lPR8
Our systematic review on novel strategies to reduce allograft ischemia-reperfusion injury in liver transplantation for HCC has been published at @CurrentOncology! As a future transplant surgeon, I couldn't be happier to be part of this team! Link: bit.ly/3V7lPR8
Whipple with artery-first approach for tumour involving SMV, reconstructed with bovine pericardial patch @DalHPB @hpb_so @SoMeTransplant @IHPBA @CHPBAsurg @DALsurgresearch
Anyone still do #ThrowbackThursdays? Beautiful shot of the @Beechcraft King Air 200 that flies us around Atlantic Canada for organ procurement! Thx to our fantastic pilots, coordinators, & all staff for making these trips so smooth! @cst_transplant @ASTSChimera @HfxStanfield

Some complex MIS content from our @DalHPB program: Lap approach to metastatic porto-caval lymph nodes. Full vid w/narration on YT m.youtube.com/watch?v=0EfYB2… @CAGS_ACCG @cutitoutPODCAS1 @AHPBA @CHPBAsurg @SAGES_Updates
Learning, debating, reconnecting with friends, making new ones, & trying new experiences (including meeting some gators!) - #AHPBA24 @AHPBA had it all!! Can’t wait to be back next year!
Strong work by our kidney transplant surgeons! 🔪 @LegacyofLifeHI @CNTRP @CAGS_ACCG @CuaJournal
Seems fitting finishing off a marathon five kidney transplants in 30 hours on #GreenShirtDay here @DalUrology @DalHPB
Looking forward to some sunshine & fantastic HPB content at #AHPBA24 @AHPBA annual meeting! Great representation from @DalHPB @QueensGenSurg & the @CHPBAsurg 🇨🇦 community!
It’s #WorldCCADay today! #cholangiocarcinoma #cancer @c3_cholangio @curecc More research needed to provide more treatment options for patients. And when trial data supports a treatment it needs to be approved in Canada!!!! (Can we say pemigatinib!)
This is great to see but very concerning that in Canada our BTC patients do not have access to even one FGFR targeted treatment. To see what many in the world are getting access too is amazing for them and disappointing in Canada! #GI24 #biliarytract
🔥Efficacy & safety results of FGFR1-3 inhibitor tinengotinib in patients cholangiocarcinoma #GI24 ✅ Results from phase II clinical trial 👉FGFR2 naive & pretreated pts 👉Consistent efficacy 👉ORR: 26 - 40%, DCR 90% 🧐Feasible & safe, phs-III ongoing @myESMO @ILCA @EASLedu…